Type de formulation: Format de conjugué anticorps-médicament (ADC) combinant un anticorps monoclonal avec une charge cytotoxique via un lieur chimique
Pureté: Caractérisation analytique de la pureté de conjugaison, du ratio médicament-anticorps (DAR) et de la teneur en médicament libre
Système d'expression: Composant d'anticorps monoclonal produit via des systèmes d'expression en cellules de mammifères (par ex. CHO)

Autres informations

Description supplémentaire:

Antibody-drug conjugates (ADCs) are among the most promising new drug classes for cancers difficult to treat with conventional chemotherapy, seen as the next major advance in cancer therapy. ALL Chemistry Inc. offers state-of-the-art ADC technologies tailored to each customer's needs, delivering improved accuracy and reproducibility, reduced synthesis cost and time, greater control over reaction conditions, better scalability, and higher efficiency in synthesizing complex molecules.